DRTS vs CRMD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CRMD Captures Institutional Edge (2โ2 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CorMedix Inc. (CRMD) driven by superior Valuation, Growth & Margin while DRTS counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, DRTS trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CRMD at 29.5x Forward P/E and 41.0% operating margin (-47.7% YoY). In options structure, DRTS sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro) against CRMD sits in BREAKDOWN (90th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DRTS | CRMD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.2B | $370.6M | Larger Scale | DRTS |
| Trailing P/E Ratio Valuation | N/M | 2.4x | Lower Multiple | CRMD |
| Forward P/E Ratio Valuation | N/M | 29.5x | Lower Multiple | CRMD |
| Revenue Growth (YoY) Growth | +0.0% | -47.7% | Higher Growth | DRTS |
| Operating Margin (TTM) Profitability | 0.0% | 41.0% | Higher Margin | CRMD |
| Net Profit Margin Profitability | 0.0% | 15.5% | Higher Margin | CRMD |
| Return on Equity (ROE) Capital Efficiency | -141.7% | 15.3% | Higher ROE | CRMD |
| 52-Week Range Position Momentum | 70% ($3โ$16) | 0% ($5โ$13) | Stronger Trend | DRTS |
| Beta / 30D Volatility Risk Regime | 1.71ฮฒ ยท 62% Vol | 1.22ฮฒ ยท 103% Vol | Lower Realized Risk | DRTS |
| Unified Institutional Score Composite Signal | 43.3 / 100 (HOLD) | 55.5 / 100 (HOLD) | Higher Composite | CRMD |